Kcentra 1000 units 1S
Ended Awarded
- Contract number
- SPE2DR26FBTBV
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,213
Award facts
- Contract value 100% obligated
- $3,213.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $3,213.28 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for 1,000 units of Kcentra. The contract is firm fixed-price with no set-aside designation and is scheduled for ultimate completion on November 24, 2025. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was awarded on November 13, 2025, with a $499.999 billion ceiling value and completion date of December 31, 2036.
The PPV-G GEN V program represents a $30.3 billion Defense Logistics Agency acquisition strategy that establishes multiple regional prime vendor contractors to supply comprehensive pharmaceutical products and medical consumables to Department of Defense healthcare facilities worldwide. Under this framework, DMS Pharmaceutical Group supplies branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables to support recurring military medical supply needs. Kcentra, a prothrombin complex concentrate used to reverse warfarin anticoagulation, aligns with the company's portfolio of critical emergency and specialty medications. The company's established performance across numerous delivery orders demonstrates its capability to fulfill the diverse pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FBTBV?
SPE2DR26FBTBV was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 10, 2025.
How much is contract SPE2DR26FBTBV worth?
The government has obligated $3,213 on SPE2DR26FBTBV.
Is contract SPE2DR26FBTBV an order under another contract?
Yes. SPE2DR26FBTBV is a delivery order under SPE2DR25D9628, an indefinite delivery contract.
Was contract SPE2DR26FBTBV competed?
The extent of competition for SPE2DR26FBTBV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award